Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Labs355.9M48.95%
Point of Care205.6M28.28%
Immunohematology132M18.15%
Donor Screening28M3.85%
Molecular Diagnostics5.6M0.77%
Region
Currency:USD
2022/FY
Stock NameRevenueRatio
Domestic2.45B75.07%
Other302.7M9.27%
China220M6.74%
Europe, Middle East and Africa (EMEA)206.8M6.33%
North America84.8M2.60%